ABSTRACT
We used a rabbit model to assess the effects of capsular serotype, genetic background and beta-lactam resistance on the course and severity of experimental meningitis. Meningitis was induced by five pneumococcal strains belonging to five different clones with known invasive potential: two serotype 3 strains (ST260(3) and Netherlands(3)-31 clones) and three serotype 23F strains with different beta-lactam susceptibility patterns (Spain(23F)-1 clone, Tennessee(23F)-4 clone and a double locus variant of the Tennessee(23F)-4 clone). Major differences in secondary bacteremia and mortality rates were observed between serotypes 3 and 23F, as were divergences in the CSF lactate, protein and lipoteichoic-teichoic acid concentrations. Minor differences in the CSF-induced inflammatory response were found among strains belonging to the same serotype. Our results suggest that capsular serotype might be the main factor determining the course and severity of pneumococcal meningitis and genetic background contributes to a lesser extent. The acquisition of beta-lactam resistance does not reduce the virulence of the invasive clones. Since five strains belonging to two serotypes were studied, our findings have to be confirmed with other pneumococcal serotypes.
Subject(s)
Meningitis, Pneumococcal/microbiology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/pathogenicity , beta-Lactam Resistance , Adult , Animals , Bacteremia/microbiology , Bacterial Capsules/immunology , Blood/microbiology , Cerebrospinal Fluid/chemistry , Cerebrospinal Fluid/microbiology , Colony Count, Microbial , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Humans , Infant , Lactic Acid/cerebrospinal fluid , Lipopolysaccharides/cerebrospinal fluid , Meningitis, Pneumococcal/pathology , Microbial Sensitivity Tests , Pneumococcal Infections/microbiology , Proteins/analysis , Rabbits , Serotyping , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/genetics , Teichoic Acids/cerebrospinal fluid , VirulenceABSTRACT
In animal models of Streptococcus pneumoniae meningitis, rifampin is neuroprotective in comparison to ceftriaxone. So far it is not clear whether this can be generalized for other protein synthesis-inhibiting antimicrobial agents. We examined the effects of the bactericidal protein synthesis-inhibiting clindamycin (n = 12) on the release of proinflammatory bacterial components, the formation of neurotoxic compounds and neuronal injury compared with the standard therapy with ceftriaxone (n = 12) in a rabbit model of pneumococcal meningitis. Analysis of the CSF and histological evaluation were combined with microdialysis from the hippocampal formation and the neocortex. Compared with ceftriaxone, clindamycin reduced the release of lipoteichoic acids from the bacteria (p = 0.004) into the CSF and the CSF leucocyte count (p = 0.011). This led to lower extracellular concentrations of hydroxyl radicals (p = 0.034) and glutamate (p = 0.016) in the hippocampal formation and a subsequent reduction of extracellular glycerol levels (p = 0.018) and neuronal apoptosis in the dentate gyrus (p = 0.008). The present data document beneficial effects of clindamycin compared with ceftriaxone on various parameters linked with the pathophysiology of pneumococcal meningitis and development of neuronal injury. This study suggests neuroprotection to be a group effect of bactericidal protein synthesis-inhibiting antimicrobial agents compared with the standard therapy with beta-lactam antibiotics in meningitis.
Subject(s)
Anti-Bacterial Agents/pharmacology , Brain/metabolism , Ceftriaxone/pharmacology , Clindamycin/pharmacology , Meningitis, Pneumococcal/physiopathology , Neuroprotective Agents/pharmacology , Animals , Body Temperature/drug effects , Cell Line, Tumor , Cerebrospinal Fluid/microbiology , Cerebrospinal Fluid Proteins/metabolism , Colony Count, Microbial , Glutamic Acid/metabolism , Glycerol/metabolism , Humans , Lactic Acid/cerebrospinal fluid , Lactic Acid/metabolism , Leukocyte Count , Lipid Peroxidation , Lipopolysaccharides/cerebrospinal fluid , Male , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/metabolism , Meningitis, Pneumococcal/microbiology , Microdialysis , Rabbits , Teichoic Acids/cerebrospinal fluid , Tyrosine/biosynthesisABSTRACT
Rifampin (RIF) releases smaller quantities of lipoteichoic acids (LTAs) from Streptococcus pneumoniae than ceftriaxone (CRO). Due to the rapid development of resistance, RIF cannot be used as a single agent for therapy of bacterial meningitis. For this reason, we compared the effect of treatment with RIF followed by treatment with CRO (RIF-CRO) or the effect of treatment with clindamycin (CLI) followed by treatment with CRO (CLI-CRO) to that of CRO alone on the concentrations of LTAs and teichoic acids in vitro. The effects of RIF-CRO on LTA concentrations in cerebrospinal fluid (CSF) and on neuronal injury were investigated in a rabbit model of S. pneumoniae meningitis. In vitro, bacterial titers were effectively reduced by CRO, RIF-CRO, and CLI-CRO when each drug was used at 10 micro g/ml. The levels of release of LTAs after the initiation of therapy were lower in RIF-CRO- and CLI-CRO-treated cultures than in cultures treated with CRO alone (P < 0.05 from 3 to 12 h after initiation of treatment). Similarly, in rabbits, the increase in the amount of LTAs in CSF was lower in RIF-CRO-treated animals than in CRO-treated animals (P = 0.02). The density of dentate apoptotic granular cells was lower after RIF-CRO therapy than after CRO therapy (medians, 58.4 and 145.6/mm(2), respectively; 25th quartiles, 36.3 and 81.7/mm(2), respectively; 75th quartiles, 100.7 and 152.3/mm(2), respectively; P = 0.03). Therefore, initiation of therapy with a protein synthesis-inhibiting antibacterial and continuation of therapy with a combination that includes a beta-lactam may be a strategy to decrease neuronal injury in bacterial meningitis.
Subject(s)
Ceftriaxone/administration & dosage , Lipopolysaccharides/cerebrospinal fluid , Meningitis, Pneumococcal/drug therapy , Neurons/pathology , Rifampin/administration & dosage , Teichoic Acids/cerebrospinal fluid , Animals , Ceftriaxone/therapeutic use , Drug Therapy, Combination , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/pathology , RabbitsABSTRACT
Lipoteichoic and teichoic acids are components of the cell wall of Streptococcus pneumoniae. A recently developed enzyme immunoassay was used in patients with pneumococcal meningitis to investigate lipoteichoic and teichoic acid concentrations in CSF at the first lumbar puncture in relation to the clinical outcome determined by the Glasgow Outcome Scale. Lipoteichoic and teichoic acid concentrations in CSF were significantly associated with neurologic sequelae and mortality in S. pneumoniae meningitis.
Subject(s)
Lipopolysaccharides/cerebrospinal fluid , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/physiopathology , Teichoic Acids/cerebrospinal fluid , Adolescent , Adult , Aged , Aged, 80 and over , Child, Preschool , Disability Evaluation , Female , Glasgow Coma Scale , Humans , Immunoenzyme Techniques/methods , Infant , Infant, Newborn , Male , Meningitis, Pneumococcal/complications , Meningitis, Pneumococcal/mortality , Middle Aged , Nervous System Diseases/etiology , Osmolar Concentration , Spinal PunctureABSTRACT
In the rabbit model of Streptococcus pneumoniae meningitis, treatment with rifabutin, quinupristin-dalfopristin, moxifloxacin and trovafloxacin led to smaller increases of the CSF concentrations of the pro-inflammatory cell wall components lipoteichoic and teichoic acids (LTA and TA) than did treatment with ceftriaxone. Low doses of moxifloxacin were associated with higher LTA and TA concentrations in CSF than were high doses.
Subject(s)
Aza Compounds , Ceftriaxone/administration & dosage , Fluoroquinolones , Lipopolysaccharides/cerebrospinal fluid , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/drug therapy , Quinolines , Rifabutin/administration & dosage , Teichoic Acids/cerebrospinal fluid , Virginiamycin/administration & dosage , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents/administration & dosage , Cephalosporins/administration & dosage , Disease Models, Animal , Immunoenzyme Techniques , Moxifloxacin , Naphthyridines/administration & dosage , Polysaccharides, Bacterial/cerebrospinal fluid , Rabbits , Reference ValuesABSTRACT
The inflammatory response following initiation of antibiotic therapy and parameters of neuronal damage were compared during intravenous treatment with quinupristin/dalfopristin (100 mg/kg as either a short or a continuous infusion) and ceftriaxone (10 mg/kg/h) in a rabbit model of Streptococcus pneumoniae meningitis. With both modes of administration, quinupristin/dalfopristin was less bactericidal than ceftriaxone. However, the concentration of proinflammatory cell wall components (lipoteichoic acid (LTA) and teichoic acid (TA)) and the activity of tumour necrosis factor (TNF) in cerebrospinal fluid (CSF) were significantly lower in the two quinupristin/dalfopristin groups than in ceftriaxone-treated rabbits. The median LTA/TA concentrations (25th/75th percentiles) were as follows: (i) 14 h after infection: 133 (72/155) ng/mL for continuous infusion of quinupristin/dalfopristin and 193 (91/308) ng/mL for short duration infusion, compared with 455 (274/2042) ng/mL for ceftriaxone (P = 0.002 and 0.02 respectively); (ii) 17 h after infection: 116 (60/368) ng/mL for continuous infusion of quinupristin/dalfopristin and 117 (41/247) ng/mL for short duration infusion, compared with 694 (156/2173) ng/mL for ceftriaxone (P = 0.04 and 0.03 respectively). Fourteen hours after infection the median TNF activity (25th/75th percentiles) was 0.2 (0.1/1.9) U/mL for continuous infusion of quinupristin/dalfopristin and 0.1 (0.01/3.5) U/mL for short duration infusion, compared with 30 (4.6/180) U/mL for ceftriaxone (P = 0.02 for each comparison); 17 h after infection the TNF activity was 2.8 (0.2/11) U/mL (continuous infusion of quinupristin/dalfopristin) and 0.1 (0.04/6.1) U/mL (short duration infusion), compared with 48.6 (18/169) U/mL for ceftriaxone (P = 0.002 and 0.001). The concentration of neuron-specific enolase (NSE) 24 h after infection was significantly lower in animals treated with quinupristin/dalfopristin: 4.6 (3.3/5.7) microg/L (continuous infusion) and 3.6 (2.9/4.7) microg/L (short duration infusion) than in those treated with ceftriaxone (17.7 (8.8/78.2) microg/L) (P = 0.03 and 0.009 respectively). In conclusion, antibiotic treatment with quinupristin/dalfopristin attenuated the inflammatory response within the subarachnoid space after initiation of antibiotic therapy. The concentration of NSE in the CSF, taken as a measure of neuronal damage, was lower in quinupristin/dalfopristin-treated rabbits than in ceftriaxone-treated rabbits.
Subject(s)
Anti-Bacterial Agents/pharmacology , Meningitis, Pneumococcal/drug therapy , Phosphopyruvate Hydratase/cerebrospinal fluid , Virginiamycin/analogs & derivatives , Animals , Ceftriaxone/pharmacology , Cerebrospinal Fluid Proteins/metabolism , Disease Models, Animal , Inflammation/drug therapy , Lactic Acid/cerebrospinal fluid , Lipopolysaccharides/cerebrospinal fluid , Meningitis, Pneumococcal/microbiology , Microbial Sensitivity Tests , Neurons/drug effects , Neurons/pathology , Phosphopyruvate Hydratase/drug effects , Rabbits , Streptococcus pneumoniae/drug effects , Subarachnoid Space/drug effects , Subarachnoid Space/microbiology , Teichoic Acids/cerebrospinal fluid , Tumor Necrosis Factor-alpha/cerebrospinal fluid , Virginiamycin/pharmacologyABSTRACT
A newly developed enzyme immunoassay (EIA) was used to detect the presence of pneumococcal teichoic and lipoteichoic acids in cerebrospinal fluid (CSF) from patients with Streptococcus pneumoniae meningitis who were being treated with antibiotics. All initial CSF samples, which on culture grew S. pneumoniae, were positive in the EIA. A total of 14 subsequent culture-negative samples gave clear signals in the EIA up to day 15 after the onset of antibiotic treatment. For 11 CSF specimens, culture, microscopy, and latex agglutination were negative while the EIA detected pneumococcal antigens. The EIA did not react either with CSF of patients with meningitis caused by bacteria other than S. pneumoniae or by viral pathogens. In conclusion, this EIA can be a valuable tool for the diagnosis of S. pneumoniae meningitis from CSF samples in cases in which prior antimicrobial therapy minimizes the usefulness of culture or other antigen detection tests.